CVS Health Stock Shows Improved Relative Price Performance

In a welcome move, CVS Health (CVS) stock saw its Relative Strength Rating rise from 69 to 72 on Tuesday.

When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.

This proprietary rating tracks market leadership by showing how a stock’s price movement over the last 52 weeks compares to that of the other stocks in our database.

History reveals that the top-performing stocks often have an RS Rating north of 80 in the early stages of their moves. See if CVS Health can continue to rebound and hit that benchmark.

Looking For The Best Stocks To Buy And Watch? Start Here

Is CVS Health Stock A Buy?

CVS Health stock is working on a cup without handle with a 90.71 buy point. See if it can break out in heavy trade. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips. Also, check out “Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks.”


Earnings growth slowed in the most recent report from 7% to -8%. But sales moved higher, from 4% to 11%.

CVS Health stock earns the No. 1 rank among its peers in the Retail-Drug Stores industry group.


MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Most Related Links :
newsbinding Governmental News Finance News

Source link

Back to top button